Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus
- PMID: 7543582
- PMCID: PMC189395
- DOI: 10.1128/JVI.69.9.5461-5468.1995
Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus
Abstract
Quiescent primary B lymphocytes are efficiently immortalized by Epstein-Barr virus (EBV). This process requires both the delivery and expression of the viral genome and results in activation of the cell division cycle. Infection of B lymphocytes depends on a direct interaction between the viral glycoprotein gp340/220 and CD21, the C3dg complement receptor. This interaction is required for the adsorption of EBV. In addition, several lines of evidence suggest that the interaction of EBV with CD21 modulates the phenotype of cells. CD21 forms part of a multimeric signal transduction complex with CD19, TAPA-1, and Leu-13. In normal B lymphocytes, CD19 becomes tyrosine phosphorylated following stimulation of the antigen receptor and recruits the signal-transducing enzyme phosphatidylinositol 3-kinase kinase. Here, we investigated the involvement of signal transduction pathways in efficient infection. Protein synthesis is not required for events leading to the transcription of the viral genome, suggesting that the early stages of infection do not depend on the expression of novel cell genes and consistent with the Wp promoter being the first viral promoter used upon infection. Since the stimulation of cells with gp340/220 leads to an increase in the level of CD19 tyrosine phosphorylation, we investigated the potential contribution of both tyrosine and phosphatidylinositol 3-kinase kinases to efficient infection. Both kinases contribute to the posttranscriptional control of viral gene expression following infection, but neither is required for the entry or initial transcription of the virus. Thus, it appears that EBV exploits a host signal transduction pathway to efficiently infect primary cells.
Similar articles
-
Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection.J Gen Virol. 1996 Dec;77 ( Pt 12):3077-85. doi: 10.1099/0022-1317-77-12-3077. J Gen Virol. 1996. PMID: 9000100
-
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.J Virol. 1990 Mar;64(3):1002-13. doi: 10.1128/JVI.64.3.1002-1013.1990. J Virol. 1990. PMID: 2154588 Free PMC article.
-
Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.J Immunol. 1994 Nov 15;153(10):4448-57. J Immunol. 1994. PMID: 7525704
-
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.Annu Rev Immunol. 1995;13:127-49. doi: 10.1146/annurev.iy.13.040195.001015. Annu Rev Immunol. 1995. PMID: 7542009 Review.
-
The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.Curr Opin Immunol. 1993 Jun;5(3):341-8. doi: 10.1016/0952-7915(93)90051-s. Curr Opin Immunol. 1993. PMID: 7688513 Review.
Cited by
-
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.J Virol. 2007 Jan;81(2):1037-42. doi: 10.1128/JVI.01416-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079287 Free PMC article.
-
Epstein-Barr virus entry.J Virol. 2007 Aug;81(15):7825-32. doi: 10.1128/JVI.00445-07. Epub 2007 Apr 25. J Virol. 2007. PMID: 17459936 Free PMC article. Review. No abstract available.
-
Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction.J Exp Med. 1997 Aug 29;186(5):731-7. doi: 10.1084/jem.186.5.731. J Exp Med. 1997. PMID: 9271588 Free PMC article.
-
Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.J Virol. 1998 Mar;72(3):1775-81. doi: 10.1128/JVI.72.3.1775-1781.1998. J Virol. 1998. PMID: 9499027 Free PMC article.
-
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.J Virol. 1997 Jul;71(7):5051-9. doi: 10.1128/JVI.71.7.5051-5059.1997. J Virol. 1997. PMID: 9188570 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials